GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Autonomix Medical AMIX · USD

N/A · US listing · 🇺🇸 United States

Compare

1.70

+11.84%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Net income

−$16.7m

FY2022FY2026

Free cash flow

−$12.3m

FY2022FY2026

Shareholders' equity

$5.9m

FY2022FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Gross profit−$12,000−$183,000−$81,000——
Research and development$7.1m$4.7m$2.2m$745,000$4,069
Operating income−$17.0m−$11.6m−$12.0m−$2.0m−$13.6m
Net income−$16.7m−$11.4m−$15.4m−$2.0m−$13.3m
Diluted earnings per share-30.74-26.75-174.90-41.20-298.18

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Total assets$7.6m$9.8m$9.4m$865,000$2.1m
Cash and short-term investments$7.0m$9.1m$8.6m$865,000$2.0m
Total liabilities$1.7m$1.7m$1.8m$221,000$93,242
Debt——$1.0m——
Shareholders' equity$5.9m$8.1m$7.6m$644,000$2.0m
Shares outstanding1m0m0m0m0m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Cash from operations−$12.3m−$8.3m−$6.6m−$1.9m−$387,307
Capital spending−$10,000−$14,000−$19,000−$2−$3
Free cash flow−$12.3m−$8.3m−$6.7m−$1.9m−$387,310

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue—————$86,000——
Gross profit—−$3,000−$4,000−$2,000−$3,000−$48,000−$47,000−$45,000
Operating income−$2.8m−$2.7m−$3.3m−$7.5m−$3.4m−$3.3m−$2.7m−$2.8m
Net income−$2.7m−$2.7m−$3.3m−$7.5m−$3.3m−$3.2m−$2.7m−$2.8m
Diluted earnings per share-5.02-4.90-7.65-17.47-7.82-7.48-30.75-31.83
Cash from operations−$3.0m−$2.0m−$2.0m−$2.0m−$2.0m−$2.0m−$2.0m−$1.0m
Total assets$4.0m$7.6m$10.2m$7.9m$9.0m$9.8m$12.0m$5.4m
Cash and short-term investments$3.5m$7.0m$9.9m$7.5m$8.6m$9.1m$11.8m$5.2m
Debt——————$1.1m$1.1m
Shareholders' equity$3.2m$5.9m$8.6m$6.4m$7.0m$8.1m$9.7m$3.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income104.6%——
Net income103.3%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024
Price to earnings-0.1-0.3-0.3

Share price return

Finished calendar years

20252024
Return-80%-93%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 21-to-1 reverse split · 24 Jun 2026
  • 20-to-1 reverse split · 25 Oct 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.